Benzinga's Top Initiations

By: via Benzinga
Analysts at SunTrust Robinson Humphrey initiated coverage on Regeneron Pharmaceuticals Inc (NASDAQ: REGN) with a Neutral rating. The ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.